BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,595,287 | +3.1% | 225,323 | +2.5% | 0.02% | +11.1% |
| Q2 2023 | $1,546,927 | -15.5% | 219,734 | +0.1% | 0.02% | -18.2% |
| Q1 2023 | $1,830,722 | -57.6% | 219,511 | -41.6% | 0.02% | -59.3% |
| Q4 2022 | $4,314,505 | +65.6% | 375,828 | +81.8% | 0.05% | +54.3% |
| Q3 2022 | $2,605,000 | +19.1% | 206,738 | 0.0% | 0.04% | +25.0% |
| Q2 2022 | $2,187,000 | -36.1% | 206,738 | -1.8% | 0.03% | -22.2% |
| Q1 2022 | $3,424,000 | +16.7% | 210,565 | -0.6% | 0.04% | +20.0% |
| Q4 2021 | $2,934,000 | +11.3% | 211,858 | +15.5% | 0.03% | +15.4% |
| Q3 2021 | $2,636,000 | – | 183,433 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |